Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Exposure Delayed Effects | 3 | 2012 | 164 | 0.970 |
Why?
|
| Smoking | 4 | 2015 | 837 | 0.790 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2012 | 57 | 0.720 |
Why?
|
| Maternal Exposure | 1 | 2012 | 40 | 0.380 |
Why?
|
| Paternal Behavior | 1 | 2011 | 6 | 0.360 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2011 | 17 | 0.360 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 197 | 0.360 |
Why?
|
| Maternal Behavior | 1 | 2011 | 31 | 0.350 |
Why?
|
| Self Report | 2 | 2015 | 369 | 0.350 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 189 | 0.320 |
Why?
|
| Cluster Analysis | 3 | 2016 | 252 | 0.300 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 392 | 0.270 |
Why?
|
| Substance Abuse Detection | 2 | 2016 | 39 | 0.250 |
Why?
|
| Cohort Studies | 3 | 2012 | 2480 | 0.180 |
Why?
|
| Birth Weight | 2 | 2010 | 84 | 0.160 |
Why?
|
| Pregnancy | 3 | 2012 | 2361 | 0.160 |
Why?
|
| Monitoring, Ambulatory | 2 | 2016 | 56 | 0.150 |
Why?
|
| Fuzzy Logic | 2 | 2016 | 5 | 0.120 |
Why?
|
| Secondary Prevention | 1 | 2016 | 154 | 0.120 |
Why?
|
| Wearable Electronic Devices | 1 | 2016 | 65 | 0.120 |
Why?
|
| Cocaine-Related Disorders | 1 | 2015 | 76 | 0.120 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 114 | 0.120 |
Why?
|
| Drug Overdose | 1 | 2016 | 121 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2015 | 280 | 0.110 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2013 | 20 | 0.110 |
Why?
|
| Young Adult | 3 | 2013 | 4398 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1239 | 0.100 |
Why?
|
| Plasmodium falciparum | 1 | 2013 | 135 | 0.100 |
Why?
|
| Malaria, Falciparum | 1 | 2013 | 119 | 0.100 |
Why?
|
| Female | 8 | 2016 | 31226 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 510 | 0.090 |
Why?
|
| Infant Behavior | 1 | 2010 | 4 | 0.090 |
Why?
|
| Telemedicine | 1 | 2016 | 337 | 0.090 |
Why?
|
| Boston | 1 | 2012 | 336 | 0.090 |
Why?
|
| Bias | 1 | 2010 | 106 | 0.090 |
Why?
|
| Social Class | 1 | 2011 | 126 | 0.090 |
Why?
|
| Adult | 5 | 2016 | 15972 | 0.080 |
Why?
|
| Smoking Cessation | 1 | 2015 | 538 | 0.080 |
Why?
|
| Achievement | 1 | 2009 | 27 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2010 | 1315 | 0.080 |
Why?
|
| Models, Psychological | 1 | 2009 | 93 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2016 | 470 | 0.080 |
Why?
|
| Child Development | 1 | 2009 | 79 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2009 | 115 | 0.070 |
Why?
|
| Humans | 9 | 2016 | 60081 | 0.070 |
Why?
|
| Child | 3 | 2013 | 4313 | 0.070 |
Why?
|
| Skin Temperature | 2 | 2016 | 18 | 0.070 |
Why?
|
| Galvanic Skin Response | 2 | 2016 | 23 | 0.060 |
Why?
|
| Adolescent | 3 | 2013 | 5944 | 0.060 |
Why?
|
| Male | 6 | 2016 | 27951 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 2615 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2010 | 3133 | 0.050 |
Why?
|
| Wrist | 1 | 2016 | 32 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 61 | 0.030 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2016 | 75 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2015 | 28 | 0.030 |
Why?
|
| Motion | 1 | 2015 | 55 | 0.030 |
Why?
|
| Locomotion | 1 | 2016 | 111 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 361 | 0.030 |
Why?
|
| Culture | 1 | 2015 | 76 | 0.030 |
Why?
|
| Cocaine | 1 | 2015 | 87 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 806 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2015 | 162 | 0.030 |
Why?
|
| Middle Aged | 3 | 2015 | 16542 | 0.030 |
Why?
|
| Family | 1 | 2015 | 224 | 0.030 |
Why?
|
| Hemoglobin, Sickle | 1 | 2013 | 7 | 0.030 |
Why?
|
| Parasitemia | 1 | 2013 | 35 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 41 | 0.030 |
Why?
|
| Kenya | 1 | 2013 | 83 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 443 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 930 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2013 | 147 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 176 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 448 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 628 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 450 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1565 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2013 | 550 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1006 | 0.020 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2009 | 35 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 173 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 376 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1522 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1038 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1839 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 353 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1527 | 0.020 |
Why?
|
| United States | 1 | 2015 | 7622 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 13596 | 0.010 |
Why?
|